Drug intelligence / Profile preview

menthyl valerate

Development stage
Unknown
Lead developer
Irbitsky Chemical-Pharmaceutical Plant
Modality
Small Molecules
Administration
Sublingual, Oral
01

Overview

Menthyl valerate is an ester formed from menthol and valeric acid. It is a colorless to pale yellow oily liquid with a characteristic odor of menthol and valerian. Menthyl valerate is used primarily as a flavoring agent in the food industry and as an active ingredient in certain anxiolytic medications—most notably under the brand name Validol. In pharmaceutical use (especially in Eastern Europe), it is often combined with free menthol (about 25–30%) to form sublingual tablets or lozenges for relief of nervous tension, anxiety, functional cardialgias (chest pain not related to heart disease), neuroses, and as an antiemetic for motion sickness[4][5][6][7][8][9]. The mechanism of action appears to involve mild sedative effects through positive allosteric modulation of GABAA receptors[5], leading to anxiolytic and calming properties.

Brand names
ValidolExtravalerianicValofinMenthoval
Other names
menthyl valerate5-methyl-2-(propan-2-yl)cyclohexyl pentanoate(1.alpha.,2.beta.,5.alpha.)-3-methylbutanoic acid 5-methyl-2-(1-methylethyl)cyclohexyl estermenthylvalerianat
02

Targets

GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on menthyl valerate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on menthyl valerate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call